language_icon
EN
HI

Vijaya Diagnostic Centre Share price

VIJAYA

1287.4

12.70 (-0.98%)
NSE
BSE
Last updated on 20 May, 2026 | 09:37 IST
Today's High

1305.00

Today's Low

1276.60

52 Week Low

848.00

52 Week High

1379.30

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Vijaya Diagnostic Centre Chart

Vijaya Diagnostic Centre Share Key Metrics

Volume
16238.00
Market Cap
13377.60 CR
LTQ@LTP
3@1287.40
ATP
1286.28
Var Margin
18.49 %
Circuit Range
1040.1-1560.1
Delivery %
60.04 %
Value
2.09 CR
ASM/GSM
No
Market Lot
1

Summary

Vijaya Diagnostic Centre share price is ₹1287.4 as of 20 May, 2026. The stock Vijaya Diagnostic Centre intraday movement has stayed between ₹1276.60 and ₹1305.00, while on a 52-week basis,Vijaya Diagnostic Centre price 52 week high is ₹1379.30 & its 52 week low is ₹848.00.
In terms of trading activity, Vijaya Diagnostic Centre has recorded a volume of 16238 shares, The Vijaya Diagnostic Centre has a market cap of ₹102896728 CR. The stock’s Average Traded Price (ATP) stands at ₹1286.28, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 3 @ ₹1287.40.
Vijaya Diagnostic Centre operates within a circuit range of ₹1040.10 – ₹1560.10, with a Value of ₹2.09 CR. The Delivery Percentage for the day is 60.04%. Additionally, Vijaya Diagnostic Centre currently falls under the No framework, and trades with a market lot size of 1.

Vijaya Diagnostic Centre Fundamentals

View More
P/E Ratio

77.35

P/B Ratio

13.98

Div. Yield

0.15

Sector P/E

56.53

Sector P/B

-15.78

Sec. Div. Yield

0.19

Vijaya Diagnostic Centre Resistance and Support

Pivot 1290.37

Resistance

First Resistance

1319.54

Second Resistance

1338.97

Third Resistance

1368.14

Support

First Support

1270.94

Second Support

1241.77

Third Support

1222.34

Vijaya Diagnostic Centre Shareholding Pattern

View More
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

52.51%

Mutual Fund

29.06%

Insurance

0.51%

Foreign Institutional Investors

13.38%

Domestic Institutional Investors

0.36%

Retail

4.18%

Others

0%

Total Promoters
MAR '26
52.51%

Vijaya Diagnostic Centre Corporate Actions

DateAgenda
2026-05-07Audited Results & Final Dividend
2026-02-13Quarterly Results
2025-11-04Quarterly Results
2025-07-28Quarterly Results
2025-05-12Audited Results & Final Dividend
2025-02-12Quarterly Results & Others

Vijaya Diagnostic Centre News

Vijaya Diagnostic Centre Ltd - 543350 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Vijaya Diagnostic Centre has scheduled two investor meetings on May 20 and 21, 2026. These meetings will be with Centrum Broking and Yes Securities, where discussions will be based on publicly available information only. No unpublished price sensitive information will be shared.
May 12 2026 12:05:00

Vijaya Diagnostic Centre Ltd - 543350 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report

Vijaya Diagnostic Centre shareholders approved the appointment of Mr. Ravi Shankararamiah and Dr. Sasikala Paruchuri Kola as Independent Directors through a postal ballot. The special resolutions passed with a requisite majority, with voting concluding on May 09, 2026.
May 11 2026 14:05:00

Vijaya Diagnostic Centre Ltd - 543350 - Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot

Vijaya Diagnostic Centre shareholders approved the appointment of two Independent Directors, Mr. Ravi Shankararamiah and Dr. Sasikala Paruchuri Kola, through postal ballot. Both Special Resolutions passed with requisite majority.
May 11 2026 14:05:00

Vijaya Diagnostic Centre Ltd - 543350 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

Company has published the audio recording of its Q4 FY26 earnings conference call, conducted on May 08, 2026. This provides investors access to discussions and insights regarding the recent financial results.
May 08 2026 16:05:00

Vijaya Diagnostic Centre Ltd - 543350 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Vijaya Diagnostic Centre reported strong Q4 FY26 results with revenue growth of 26.6% YoY to Rs.219.38 cr and net profit growth of 37.5% YoY to Rs.47.93 cr. The company achieved its highest-ever quarterly revenue, driven by volume growth and network expansion.
May 07 2026 20:05:00

Vijaya Diagnostic Centre Ltd - 543350 - Corporate Action-Board approves Dividend

Vijaya Diagnostic Centre Board recommends a final dividend of ₹2 per equity share for the financial year ended March 31, 2026. This dividend, 200% on a ₹1 face value, requires shareholder approval at the upcoming AGM.
May 07 2026 19:05:00

Vijaya Diagnostic Centre Ltd - 543350 - Board Meeting Outcome for Outcome Of The Board Meeting Held On May 07, 2026

Vijaya Diagnostic board approved audited financial results for FY26 and recommended a final dividend of ₹2 per equity share. The company also acquired MRI, EEG, and NCV services business from its wholly-owned subsidiary, Medinova Millennium MRI Services LLP, for ₹4.20 crore in cash.
May 07 2026 19:05:00
Read More

About Vijaya Diagnostic Centre

NSE : 5585  
BSE : 543350  
ISIN : INE043W01024  

The Company was incorporated as Vijaya Diagnostic Centre Private Limited on June 5 2002 with a certificate of incorporation issued by the Registrar of Companies Andhra Pradesh at Hyderabad. Subsequently the Company was converted from a private limited company to a public limited company pursuant to a special resolution passed by the Shareholders at the EGM held on March 22 2021 and the name of the Company was changed to Vijaya Diagnostic Centre Limited and accordingly on March 26 2021 a fresh certificate of incorporation consequent on change of name was granted by the RoC. The Company had historically in various public documents such as annual reports and secretarial filings named Dr. S. Surendranath Reddy S. Geeta Reddy Sunil Chandra Kondapally Sura Suprita Reddy and B. Vishnu Priya as the promoters. Pursuant to a resolution of the Board in its meeting held on May 27 2021 it was resolved that Dr. S. Surendranath Reddy will be the Promoter of the Company.Major events and milestones of the Company :2021- First independent diagnostic centre in the State of Telangana to get Revolution ACT 50 slice CT from Wipro GE Healthcare Private Limited.2016- Investment by Karakoram Limited and Kedaara Capital Alternative Investment Fund - Kedaara Capital AIF 1.2014- Acquisition of majority shareholding in "Medinova Diagnostic Services Limited".2008- First independent diagnostic centre in South India to get PET CT from Wipro GE Healthcare Private Limited.2005- Business was transferred from proprietorship to the company.Awards accreditations and recognitions received by the Company :2021- The Company has received the ‘Award of Excellence’ as the leading Imaging Centre (Multiple City) at the Radiologyand Imaging Excellence Awards 2021- The Company was awarded the Award of Excellence for leading from the front during the pandemic under the LeadingDiagnostic Chain of the Year by Elets Technomedia Private Limited- The centre at Kurnool received scope of accreditation from National Accreditation Board for Hospitals and HealthcareProviders (“NABH”)- The centre at Karimnagar received the ISO 15189:2012 “Medical Laboratories – Requirements for quality andcompetence” for its facilities in the field of medical testing by National Accreditation Board for Testing and CalibrationLaboratories (“NABL”)- The Company received the certificate of recognition from the Economic Times as one of the Best Healthcare Brands -20212020- The Company was awarded the Most Trusted and Best Quality Diagnostic Services in India – 2020 at the COVID Warriors Awards 2020 by Topgallant Media- The centre at Himayatnagar received the ISO 15189:2012 “Medical Laboratories – Requirements for quality andcompetence” for its facilities in the field of medical testing by NABL- The centre at Sarojini Devi Road received scope of accreditation from NABH;- The centre at Dilshuknagar received the ISO 15189:2012 by NABL;- The centre at Habsiguda received the ISO 15189:2012 by NABL;- The centre at Nandyal received Certificate for fulfilment to the requirement of NABL 128 (Quality Assurance Scheme for Basic Composite Medical Laboratories – Entry Level)- The centre at Nellore received Certificate for fulfilment to the requirement of NABL 128 (Quality Assurance Scheme for Basic Composite Medical Laboratories – Entry Level).2019- The Company was awarded the Best Diagnostic Centre of the Year India – 2019 by the Times Healthcare Achievers The Times of India- The Company was awarded the Best Diagnostic Service Provider of the Year – 2019 at the Six Sigma HealthcareExcellence Awards 2019- The Promoter Dr. S. Surendranath Reddy was awarded the Healthcare Entrepreneur of the year by the Six SigmaHealthcare Excellence Awards 2019- The Company was awarded Most Trusted Diagnostic Centre of the year India – 2019 at the Indo Arab Leaders SummitAwards 2019 Dubai- The Company was recognised and honoured to be under 10 Most Trusted Brands of the Year 2019 by the BusinessSight Magazine- The centre at Kukatpally received scope of accreditation from NABH- The centre at Hanamkonda received the ISO 15189:2012 “Medical Laboratories – Requirements for quality andcompetence” for its facilities in the field of medical testing by NABL- The centre at Kurnool received the ISO 15189:2012 “Medical Laboratories – Requirements for quality andcompetence” for its facilities in the field of medical testing by NABL- The centre at Visakhapatnam received the ISO 15189:2012 “Medical Laboratories – Requirements for quality andcompetence” for its facilities in the field of medical testing by NABL.2018- The Company was awarded the Healthcare Leadership Award at the Telangana Healthcare Leadership Award 2018- The Company received the certificate of excellence and “brand of the year” award in the diagnostic services categoryby the CEO Magazine- The Company was awarded the Fastest Growing Brand (Pride of the Nation) 2018-2019 by United Research Services- The centre at Himayatnagar received the ISO 9001:2015 certification to provide medical laboratory and diagnosticservices in clinical pathology haematology biochemistry radiology and imaging nuclear medicine microbiologyserology and immunodiagnostics histo and cytopathology molecular diagnostics cytogenetics cardiology neurologypulmonology and immunohistochemistry by Bureau Veritas Certification Holding SAS -UK Branch- The centre at Gurgaon received the ISO 15189:2012 “Medical Laboratories – Requirements for quality andcompetence” for its facilities in the field of medical testing by NABL- The centre at Kolkata received the ISO 15189:2012 “Medical Laboratories – Requirements for quality and competence”for its facilities in the field of medical testing by NABL.2012- The Company was recognised as one of the Best Imaging Centres in Hyderabad the Week- Hansa Research nationalsurvey 2012.

Read More

Vijaya Diagnostic Centre Management

NamePosition
Sura Surendranath ReddyChairman
Sura S ReddyManaging Director & Chief Executive Officer
View More

Vijaya Diagnostic Centre FAQs

The Buying Price of Vijaya Diagnostic Centre share is 1287.4 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Vijaya Diagnostic Centre stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Vijaya Diagnostic Centre, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Vijaya Diagnostic Centre shares is 77.35. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Vijaya Diagnostic Centre shares is 13.98. Useful to assess the stock's value relative to its book value.

To assess Vijaya Diagnostic Centre’s valuation compare Sector P/E, P/B which are 56.53 & -15.78 with sector averages, along with growth rates and financial metrics.

The Market Cap of Vijaya Diagnostic Centre is 13377.60 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Vijaya Diagnostic Centre share price is 1379.30 & 848.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Vijaya Diagnostic Centre belongs to the Healthcare sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost